Skip to main content
Sheela Foam Limited logo

Sheela Foam Limited — Investor Relations & Filings

Ticker · SFL ISIN · INE916U01025 LEI · 3358009OJCM3IHW2T747 BSE.NS Manufacturing
Open in API
Filings indexed 1,175 across all filing types
Latest filing 2024-10-29 Regulatory Filings
Country IN India
Listing BSE.NS SFL

About Sheela Foam Limited

https://www.sheelafoam.com

Sheela Foam Limited is a leading manufacturer of polyurethane (PU) foam and comfort products. The company operates a diverse portfolio, most notably through its flagship brand, Sleepwell, which provides mattresses, pillows, and cushioning materials. Its technical foam division supplies specialized products for the automotive, acoustic, and industrial sectors, including flame-retardant and reticulated foams. With a robust manufacturing infrastructure and a significant international presence through subsidiaries in Australia and Europe, the company focuses on research-driven product development and advanced foam technologies. Its operations encompass a wide distribution network and integrated supply chain, catering to both retail consumers and original equipment manufacturers (OEMs) across global markets.

Recent filings

Filing Released Lang Actions
Result for Quarter and Half Year ended September 30, 2024
Regulatory Filings
2024-10-29 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is dated October 29, 2024, and it contains detailed financial results for the quarter and half year ended September 30, 2024. It includes standalone and consolidated financial results, approved by the Board of Directors, and is accompanied by an Independent Auditor's Review Report. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 33 and 52, which pertain to quarterly and half-yearly financial results. The presence of unaudited financial statements and the auditor's review report indicates this is an interim financial report rather than a full annual report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2024-10-29 English
Financial Results for Quarter ending September 30, 2024
Regulatory Filings
2024-10-29 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is an official communication from Sheela Foam Limited dated October 29, 2024, addressed to stock exchanges and regulatory bodies. It announces the outcome of a Board Meeting and includes Limited Reviewed unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2024. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulations 30, 33, and 52, which pertain to financial results disclosures. It also includes an Independent Auditor's Review Report on the unaudited financial results, indicating that the financial data and analysis are substantive and detailed. The presence of detailed financial tables and auditor review confirms this is a comprehensive interim financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2024-10-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an invitation to an investor/analyst conference call scheduled for October 30, 2024, where management will discuss financial results for the quarter and half year ended September 30, 2024. It references the upcoming call and states that the transcript will be published later on the company's website and stock exchange websites. The document does not contain actual financial data or the transcript itself, but is an announcement of the call event. Therefore, it fits the definition of a Call Transcript (CT) announcement, but since it is only an invitation and not the transcript, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement about the call. The document length is short (3025 characters), and it is not the transcript or report itself, so it is not a CT filing. Hence, the most appropriate classification is Regulatory Filings (RNS).
2024-10-25 English
Investor Meet on 30th October, 2024 to discuss Q2 2024 results
Regulatory Filings
2024-10-25 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.